Find Avanafil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

57 RELATED EXCIPIENT COMPANIES

102EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 330784-47-9, Stendra, Spedra, Ta 1790, Ta-1790, (s)-4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
Molecular Formula
C23H26ClN7O3
Molecular Weight
483.9  g/mol
InChI Key
WEAJZXNPAWBCOA-INIZCTEOSA-N
FDA UNII
DR5S136IVO

Avanafil
Avanafil is an orally available phosphodiesterase type 5 (PDE5) inhibitor with vasodilatory activity. Avanafil selectively inhibits PDE5, thus inhibiting the degradation of cyclic guanosine monophosphate (cGMP) found in the smooth muscle of the corpus cavernosa of the penis. The inhibition of cGMP degradation results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, thereby prolonging penile erection.
Avanafil is a Phosphodiesterase 5 Inhibitor. The mechanism of action of avanafil is as a Phosphodiesterase 5 Inhibitor.
1 2D Structure

Avanafil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
2.1.2 InChI
InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1
2.1.3 InChI Key
WEAJZXNPAWBCOA-INIZCTEOSA-N
2.1.4 Canonical SMILES
COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl
2.1.5 Isomeric SMILES
COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCC[C@H]4CO)Cl
2.2 Other Identifiers
2.2.1 UNII
DR5S136IVO
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide

2. Stendra

2.3.2 Depositor-Supplied Synonyms

1. 330784-47-9

2. Stendra

3. Spedra

4. Ta 1790

5. Ta-1790

6. (s)-4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

7. Chebi:66876

8. Dr5s136ivo

9. (s)-2-(2-hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine

10. (s)-4-(3-chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-n-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide

11. (s)-4-[(3-chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-n-(2pyrimidinylmethyl)-5-pyrimidinecarboxamide

12. 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

13. 4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

14. 4-((3-chloro-4-methoxybenzyl)amino)-2-((2s)-2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

15. 5-pyrimidinecarboxamide, 4-(((3-chloro-4-methoxyphenyl)methyl)amino)-2-((2s)-2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-

16. Stendra (tn)

17. Avanafil [usan:inn]

18. Unii-dr5s136ivo

19. Zepeed

20. Ine-5-carboxamide

21. Spedra (tn)

22. Avanafil [usan]

23. Avanafil (usan/inn)

24. Avanafil [inn]

25. Avanafil [mi]

26. Avanafil [vandf]

27. Avanafil [mart.]

28. Avanafil [who-dd]

29. Avanafil 100 Microg/ml In Acetonitrile:dimethylsulfoxide

30. Schembl118799

31. Avanafil [orange Book]

32. Gtpl7448

33. Chembl1963681

34. Amy1794

35. Dtxsid50186727

36. 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide

37. Bdbm50036629

38. Cs1566

39. Mfcd11977961

40. S4019

41. Ta1790

42. Zinc11677857

43. Akos024462448

44. Ccg-229896

45. Db06237

46. Vi-0162

47. Ncgc00386241-01

48. As-20106

49. Hy-18252

50. Sw219217-1

51. D03217

52. Ab01565827_02

53. J-019006

54. Q2873270

55. Brd-k65781196-001-01-4

56. (s)-2-(2-hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[n-(2-pyrimidylmethyl)carbamoyl]-pyrimidine

57. (s)-4-[(3-chlor-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1- Pyrrolidinyl]-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamid

58. 4-[(3-chloranyl-4-methoxy-phenyl)methylamino]-2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-n-(pyrimidin-2-ylmethyl)pyrimid

59. 4-[(3-chloranyl-4-methoxy-phenyl)methylamino]-2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-n-(pyrimidin-2-ylmethyl)pyrimid Ine-5-carboxamide

60. Avanafil; (s)-4-chloro-6-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

61. E6l

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 483.9 g/mol
Molecular Formula C23H26ClN7O3
XLogP32.6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count9
Exact Mass483.1785654 g/mol
Monoisotopic Mass483.1785654 g/mol
Topological Polar Surface Area125 Ų
Heavy Atom Count34
Formal Charge0
Complexity642
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameStendra
PubMed HealthAvanafil (By mouth)
Drug ClassesErectile Dysfunction Agent
Drug LabelSTENDRA (avanafil) is a selective inhibitor of cGMP-specific PDE5.Avanafil is designated chemically as (S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide and has the following...
Active IngredientAvanafil
Dosage FormTablet
RouteOral
Strength200mg; 100mg; 50mg
Market StatusPrescription
CompanyVivus

2 of 2  
Drug NameStendra
PubMed HealthAvanafil (By mouth)
Drug ClassesErectile Dysfunction Agent
Drug LabelSTENDRA (avanafil) is a selective inhibitor of cGMP-specific PDE5.Avanafil is designated chemically as (S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide and has the following...
Active IngredientAvanafil
Dosage FormTablet
RouteOral
Strength200mg; 100mg; 50mg
Market StatusPrescription
CompanyVivus

4.2 Drug Indication

Avanafil is indicated for the treatment of erectile dysfunction.


FDA Label


Treatment of erectile dysfunction in adult men.

In order for Spedra to be effective, sexual stimulation is required.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Avanafil is a strong competitive inhibitor of phosphodiesterase 5 (PDE5) with a demonstrated _in vitro_ IC50 of 5.2 nM. Its inhibitory effects on PDE5 are 100-fold more potent than on PDE6 and >1000-fold more potent than on other PDE enzymes, meaning it is less likely to cause visual disturbances and cardiovascular adverse effects when compared with less selective PDE5 inhibitors such as [sildenafil] and [vardenafil]. It has a relatively quick onset of action allowing for administration as early as 15 minutes prior to sexual activity. PDE5 inhibitors like avanafil can cause significant drug interactions when administered alongside certain antihypertensive agents (e.g. alpha blockers, substantial amounts of alcohol). PDE5 inhibitors have also been associated with the development of non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that typically presents as sudden loss of vision in one or both eyes and appears to be more common in patients with a "crowded" optic disc. Patients presenting with any degree of vision loss should immediately discontinue use of all PDE5 inhibitors and seek medical attention. In some jurisdictions, a history of NAION or other degenerative retinal disorders is considered a contraindication to avanafil therapy.


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
AVANAFIL
5.2.2 FDA UNII
DR5S136IVO
5.2.3 Pharmacological Classes
Phosphodiesterase 5 Inhibitors [MoA]; Phosphodiesterase 5 Inhibitor [EPC]
5.3 ATC Code

G04BE10


G04BE10

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


G - Genito urinary system and sex hormones

G04 - Urologicals

G04B - Urologicals

G04BE - Drugs used in erectile dysfunction

G04BE10 - Avanafil


5.4 Absorption, Distribution and Excretion

Absorption

Avanafil is rapidly absorbed following oral administration (Tmax of 30-45 minutes) and appears to have low to moderate oral bioavailability, though formal studies have not been conducted. Administration with a meal results in a mean delay in Tmax of 1.12 to 1.25 hours, a 39% mean reduction in Cmax, and a negligible effect on AUC.


Route of Elimination

Following oral administration, avanafil is extensively metabolized. Approximately 62% of a given dose is excreted as metabolites in the feces and approximately 21% as metabolites in the urine.


Volume of Distribution

The apparent volume of distribution of avanafil is 47 to 83 L.


5.5 Metabolism/Metabolites

Avanafil is extensively metabolized, primarily by CYP3A4 and to a lesser extent by CYP2C9. There are two major metabolites formed, M4 and M16, which exist in the plasma at concentrations 23% and 29% that of the parent compound, respectively. The M16 metabolite lacks pharmacologic effect, but the M4 metabolite has an inhibitory potency for PDE5 18% that of avanafil and accounts for approximately 4% of the observed pharmacologic activity of avanafil.


5.6 Biological Half-Life

Studies have demonstrated variability in the terminal elimination half-life of avanafil, with estimates ranging between 5 - 17 hours.


5.7 Mechanism of Action

Avanafil inhibits the cGMP-specific phosphodiesterase type 5 (PDE5) which is responsible for the degradation of cGMP in the corpus cavernosum located around the penis. Sexual arousal results in the local release of nitric oxide, which in turn stimulates the enzyme guanylate cyclase to produce cGMP. Elevated levels of cGMP result in local smooth muscle relaxation and increased blood flow to the penis (i.e. an erection). As PDE5 inhibitors like avanafil require the endogenous release of nitric oxide in order to exert their pharmacologic effect, they have no effect on the user in the absence of sexual stimulation/arousal.


API SUPPLIERS

read-more
read-more

01

Polpharma

Poland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Flag Poland
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Polpharma CB

02

Sanofi

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Sanofi Company Banner

03

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

04

Century Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCentury has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Century Company Banner

05

Reyoung pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Reyoung pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

HONOUR LAB LTD

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

HONOUR LAB LTD

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

08

Vivus

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Vivus

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

10

AASraw Biochemical Technology Co.,...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil IH

Date of Issue : 2022-06-17

Valid Till : 2025-07-14

Written Confirmation Number : WC-0021n

Address of the Firm : Sy. Nos: 317, 320, 321, 322, 323, 604 & 605, Rudraram (Village), Patancheru (Man...

blank

02

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil (IH)

Date of Issue : 2019-07-15

Valid Till : 2022-07-14

Written Confirmation Number : WC-0021

Address of the Firm : Sy. No.317&323, Rudraram Village, Patancheru Mandal, Sangaredy District-502329 T...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

LGM Pharma

U.S.A
arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Avanafil

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCentury has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.

Flag India
Digital Content Digital Content

Avanafil

About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in In...

Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in India and abroad. Its APIs are manufactured in accordance with cGMP, 21CFR part 10 and ICH guidelines. It also produces intermediates and develops new APIs as per the needs of its clients. Century conducts biotechnological research that focuses on human therapeutic proteins. Currently, research is underway to find treatments for asthma, mastocytosis and basophilic leukemia. Century supplies research-grade biotech products and a wide range of animal health products.
Century Company Banner

03

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil

About the Company : Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healt...

Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healthcare Ltd. have metamorphosed into specialty company and focused on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries. Bajaj healthcare Ltd. in its shot life span has gained loyalty from national and international customers and our products enjoy good fame in the overseas market.
blank

04

DEAFARMA

Italy
Duphat
Not Confirmed
arrow

DEAFARMA

Italy
arrow
Duphat
Not Confirmed

Avanafil

About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...

In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factories. Our partners are well known, reliable producers and all of them are operating in accordance with the latest GMP Rules. The APIs mentioned in the DEAFARMA catalogue are always supported by DMF and/or CEP.
blank

05

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil

About the Company : Globofarm International Pvt Ltd is a well-informed, highly efficient, Swiftly functioning competitive sourcing entity. We serve private, institutional, and corporate clients worldw...

Globofarm International Pvt Ltd is a well-informed, highly efficient, Swiftly functioning competitive sourcing entity. We serve private, institutional, and corporate clients worldwide in the field of Pharmaceuticals & Nutraceuticals. We combine our contacts, expertise, and core competency with our operations to deliver superior pharmaceutical sourcing solutions to our customers. Having our base in India, Globofarm International Pvt Ltd has been serving clients globally.
blank

06

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil

About the Company : Gokulendu Life Science offers broad portfolio of Active Pharmaceutical Ingredients (API). We began producing Active Pharmaceutical Ingredients (APIs) in 2020 as a vital input to ...

Gokulendu Life Science offers broad portfolio of Active Pharmaceutical Ingredients (API). We began producing Active Pharmaceutical Ingredients (APIs) in 2020 as a vital input to the manufacture of Generic Formulations and Medicine. All our list of APIs is expected to customers in Domestic and Export Market.
blank

07

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

08

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil

About the Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, cat...

Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, catering to both export and import markets. The company consists of two primary business departments: the Professional Sourcing/Product Team and the Quality Team. Backed by experienced partners, Longshine has evolved into a trustworthy supplier of high-quality products and received ISO9001:2008 certification in 2017.
blank

09

Hetero Drugs

India
Duphat
Not Confirmed
arrow

Hetero Drugs

India
arrow
Duphat
Not Confirmed

Avanafil

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

10

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil

About the Company : Founded in 2003, Hyderabad-based MSN Labs is one of the fastest-growing research-based pharmaceutical company in India. Boasting a diverse product portfolio, with multiple products...

Founded in 2003, Hyderabad-based MSN Labs is one of the fastest-growing research-based pharmaceutical company in India. Boasting a diverse product portfolio, with multiple products in the market and in the pipeline, MSN has 6 API (including Oncology) and one finished dosage facilities (one more for Oncology is being built) and an integrated R&D Center for Contract Research And Manufacturing Services (CRAMS) located in Hyderabad. MSN has won the trust of more than 250 customers across 65 countries around the globe covering the US, Europe, Latin America, Middle-East, Asia Pacific, Africa and CIS markets. Our product basket offers 100 APIs
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"AVANAFIL","year":"2021","qtr":"Q1","strtotime":1609957800,"product":"AVANAFIL(TAX INV NO.G2103SE-352 DT.21.12 .2020) GST NO.37AACCH8413M3Z8","address":"PLOT NO. 7314\/8, M\/S KOHINOOR METAL GIDC ESTATE","city":"ANKLESHWAR , DIST BHARUCH, GUJARAT","supplier":"SKJ PHARMACHEM","supplierCountry":"INDIA","foreign_port":"BEIRUT","customer":"TO THE ORDER OF","customerCountry":"LEBANON","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"1449.1","totalValueFC":"1467.2","currency":"USD","unitRateINR":107308.96000000001,"date":"07-Jan-2021","totalValueINR":"107308.96","totalValueInUsd":"1467.2","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"7746597","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"LEBANON","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"PLOT NO. 7314\/8, M\/S KOHINOOR METAL GIDC ESTATE, ANKLESHWAR , DIST BHARUCH, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1622485800,"product":"AVANAFIL (TAX INVOICE NO:1900215197 DT 28-05-2021)(GROUP:B SRL NO:1522","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"GASSIM","customer":"SAUDI PHARMACEUTICAL IND.& MED. AP","customerCountry":"SAUDI ARABIA","quantity":"80.00","actualQuantity":"80","unit":"KGS","unitRateFc":"2998.6","totalValueFC":"235012.6","currency":"USD","unitRateINR":216051.92499999999,"date":"01-Jun-2021","totalValueINR":"17284154","totalValueInUsd":"235012.6","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"2146639","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623090600,"product":"AVANAFIL (TAX INVOICE NO:1900215235 DT 31-05-2021)(GROUP:B SRL:1522","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"GAVA AIRFARM LOGISTICS ","customerCountry":"UNITED ARAB EMIRATES","quantity":"11.00","actualQuantity":"11","unit":"KGS","unitRateFc":"4445.4","totalValueFC":"47905","currency":"USD","unitRateINR":320290.93181818182,"date":"08-Jun-2021","totalValueINR":"3523200.25","totalValueInUsd":"47905","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"2274995","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1634841000,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"HAMBURG","customer":"I CARGO INTERNATIONALE LOGISTIC & HANDELS GMBH","customerCountry":"GERMANY","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"3179.2","totalValueFC":"31426.5","currency":"USD","unitRateINR":235422.5,"date":"22-Oct-2021","totalValueINR":"2354225","totalValueInUsd":"31426.5","indian_port":"Vizag-HIPL SEZ","hs_no":"29335990","bill_no":"4000782","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639161000,"product":"AVANAFIL","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"MILAN","customer":"NICOX RESEARCH INSTITUTE SRL","customerCountry":"ITALY","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"5000","totalValueFC":"967.8","currency":"USD","unitRateINR":365000,"date":"11-Dec-2021","totalValueINR":"73000","totalValueInUsd":"967.8","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"6670430","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648060200,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"BOGOTA","customer":"SEVEN PHARMA COLOMBIA ","customerCountry":"COLOMBIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2175.5","totalValueFC":"10732","currency":"USD","unitRateINR":163597.20000000001,"date":"24-Mar-2022","totalValueINR":"817986","totalValueInUsd":"10732","indian_port":"Vizag-HIPL SEZ","hs_no":"29335990","bill_no":"4000225","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"COLOMBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652985000,"product":"AVANAFIL","address":"216\/6, VILL KHANDH,TALUKA CHIKHLI","city":"NAVSARI,GUJARAT","supplier":"SUYAASH PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"ALEX MEDICAL PHARMA","customerCountry":"ISRAEL","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2300","totalValueFC":"11438.1","currency":"USD","unitRateINR":176800,"date":"20-May-2022","totalValueINR":"884000","totalValueInUsd":"11438.1","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"1520466","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"216\/6, VILL KHANDH,TALUKA CHIKHLI, NAVSARI,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683484200,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"BOGOTA","customer":"SEVEN PHARMA COLOMBIA ","customerCountry":"COLOMBIA","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"2204.2","totalValueFC":"12994.8","currency":"USD","unitRateINR":178210.66666666666,"date":"08-May-2023","totalValueINR":"1069264","totalValueInUsd":"12994.8","indian_port":"Vizag-HIPL SEZ","hs_no":"29339990","bill_no":"4000353","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"COLOMBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695061800,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"HAMBURG","customer":"ALDER TRADING FZ LLC","customerCountry":"GERMANY","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"3086.4","totalValueFC":"15281.8","currency":"USD","unitRateINR":253703.20000000001,"date":"19-Sep-2023","totalValueINR":"1268516","totalValueInUsd":"15281.8","indian_port":"Vizag-HIPL SEZ","hs_no":"29339990","bill_no":"4000761","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697567400,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"BOGOTA","customer":"SEVEN PHARMA COLOMBIA ","customerCountry":"COLOMBIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"2209.2","totalValueFC":"21871.5","currency":"USD","unitRateINR":182034.70000000001,"date":"18-Oct-2023","totalValueINR":"1820347","totalValueInUsd":"21871.5","indian_port":"Vizag-HIPL SEZ","hs_no":"29339990","bill_no":"4000834","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"COLOMBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701714600,"product":"PHARMACEUTICAL RAW MATERIAL-BULK DRUG FOR USE IN PHARMACEUTICAL INDUSTRIES AVANAFIL","address":"708, TIMES SQUARE ARCADE,","city":"AHMEDABAD","supplier":"SKJ HEALTHCARE PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BEIRUT","customer":"TO THE ORDER OF","customerCountry":"LEBANON","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"1675","totalValueFC":"24566.6","currency":"USD","unitRateINR":136333.33333333334,"date":"05-Dec-2023","totalValueINR":"2045000","totalValueInUsd":"24566.6","indian_port":"Ahmedabad Air","hs_no":"29321990","bill_no":"5812621","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"LEBANON","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"708, TIMES SQUARE ARCADE,, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717439400,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"HANOI - NOIBAI","customer":"VINH PHUC PHARMACEUTICAL ","customerCountry":"VIETNAM","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2050","totalValueFC":"1916.8","currency":"USD","unitRateINR":160013.5,"date":"04-Jun-2024","totalValueINR":"160013.5","totalValueInUsd":"1916.8","indian_port":"Hyderabad Air","hs_no":"29321990","bill_no":"1415462","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"VIETNAM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"425\/3 RT D NO 7-1-621\/328,, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723573800,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"STANDARD CHARTERED BANK.","customerCountry":"BANGLADESH","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"1300","totalValueFC":"38414.5","currency":"USD","unitRateINR":107405,"date":"14-Aug-2024","totalValueINR":"3222150","totalValueInUsd":"38414.5","indian_port":"Hyderabad Air","hs_no":"29321990","bill_no":"3209241","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"425\/3 RT D NO 7-1-621\/328,, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724005800,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ASUNCION","customer":"LABORATORIOS GALENO S.A.","customerCountry":"PARAGUAY","quantity":"16.00","actualQuantity":"16","unit":"KGS","unitRateFc":"1830","totalValueFC":"28580","currency":"USD","unitRateINR":149828.0625,"date":"19-Aug-2024","totalValueINR":"2397249","totalValueInUsd":"28580","indian_port":"Hyderabad Air","hs_no":"29321990","bill_no":"3304112","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PARAGUAY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"425\/3 RT D NO 7-1-621\/328,, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725474600,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"KARACHI -","customer":"AL BARAKA BANK ","customerCountry":"PAKISTAN","quantity":"3.50","actualQuantity":"3.5","unit":"KGS","unitRateFc":"1400","totalValueFC":"4712.5","currency":"USD","unitRateINR":112832.69142857143,"date":"05-Sep-2024","totalValueINR":"394914.42","totalValueInUsd":"4712.5","indian_port":"Hyderabad Air","hs_no":"29321990","bill_no":"3787257","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"425\/3 RT D NO 7-1-621\/328,, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726684200,"product":"AVANAFIL","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SANTIAGO DE CHILE -","customer":"LABORATORIES RECALCINE SA","customerCountry":"CHILE","quantity":"13.00","actualQuantity":"13","unit":"KGS","unitRateFc":"4500","totalValueFC":"58045.4","currency":"USD","unitRateINR":374175,"date":"19-Sep-2024","totalValueINR":"4864275","totalValueInUsd":"58045.4","indian_port":"Hyderabad Air","hs_no":"29334900","bill_no":"4148203","productDescription":"API","marketType":"REGULATED MARKET","country":"CHILE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1727980200,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"PHARMANEER DRUGS INC.","customerCountry":"TAIWAN","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"2700","totalValueFC":"1237.9","currency":"USD","unitRateINR":208032,"date":"04-Oct-2024","totalValueINR":"104016","totalValueInUsd":"1237.9","indian_port":"Hyderabad Air","hs_no":"29321990","bill_no":"4570748","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"425\/3 RT D NO 7-1-621\/328,, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732213800,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"TAOYUAN","customer":"ZALOZA INTERNATIONAL CO ","customerCountry":"TAIWAN","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3000","totalValueFC":"8867.2","currency":"USD","unitRateINR":249429.66666666666,"date":"22-Nov-2024","totalValueINR":"748289","totalValueInUsd":"8867.2","indian_port":"Vizag-HIPL SEZ","hs_no":"29339990","bill_no":"5829810","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""}]
07-Jan-2021
22-Nov-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Europe

read-more
read-more

01

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

avanafil

Brand Name : Spedra

Dosage Form : TABLET

Dosage Strength : 50 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

avanafil

Brand Name : Spedra

Dosage Form : TABLET

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

avanafil

Brand Name : Spedra

Dosage Form : TABLET

Dosage Strength : 200 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil

Brand Name : Edra

Dosage Form : Avanafil 100Mg 12 Combined Oral Use

Dosage Strength : 12 CPR 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Avanafil

Brand Name : Edra

Dosage Form : Avanafil 200Mg 12 Combined Oral Use

Dosage Strength : 12 CPR 200 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 100MG

USFDA APPLICATION NUMBER - 202276

read-more

DOSAGE - TABLET;ORAL - 200MG

USFDA APPLICATION NUMBER - 202276

read-more

DOSAGE - TABLET;ORAL - 50MG

USFDA APPLICATION NUMBER - 202276

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Parenteral

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Avanafil Manufacturers

A Avanafil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Avanafil, including repackagers and relabelers. The FDA regulates Avanafil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Avanafil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Avanafil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Avanafil Suppliers

A Avanafil supplier is an individual or a company that provides Avanafil active pharmaceutical ingredient (API) or Avanafil finished formulations upon request. The Avanafil suppliers may include Avanafil API manufacturers, exporters, distributors and traders.

click here to find a list of Avanafil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Avanafil USDMF

A Avanafil DMF (Drug Master File) is a document detailing the whole manufacturing process of Avanafil active pharmaceutical ingredient (API) in detail. Different forms of Avanafil DMFs exist exist since differing nations have different regulations, such as Avanafil USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Avanafil DMF submitted to regulatory agencies in the US is known as a USDMF. Avanafil USDMF includes data on Avanafil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Avanafil USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Avanafil suppliers with USDMF on PharmaCompass.

Avanafil KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Avanafil Drug Master File in Korea (Avanafil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Avanafil. The MFDS reviews the Avanafil KDMF as part of the drug registration process and uses the information provided in the Avanafil KDMF to evaluate the safety and efficacy of the drug.

After submitting a Avanafil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Avanafil API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Avanafil suppliers with KDMF on PharmaCompass.

Avanafil WC

A Avanafil written confirmation (Avanafil WC) is an official document issued by a regulatory agency to a Avanafil manufacturer, verifying that the manufacturing facility of a Avanafil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Avanafil APIs or Avanafil finished pharmaceutical products to another nation, regulatory agencies frequently require a Avanafil WC (written confirmation) as part of the regulatory process.

click here to find a list of Avanafil suppliers with Written Confirmation (WC) on PharmaCompass.

Avanafil NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Avanafil as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Avanafil API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Avanafil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Avanafil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Avanafil NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Avanafil suppliers with NDC on PharmaCompass.

Avanafil GMP

Avanafil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Avanafil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Avanafil GMP manufacturer or Avanafil GMP API supplier for your needs.

Avanafil CoA

A Avanafil CoA (Certificate of Analysis) is a formal document that attests to Avanafil's compliance with Avanafil specifications and serves as a tool for batch-level quality control.

Avanafil CoA mostly includes findings from lab analyses of a specific batch. For each Avanafil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Avanafil may be tested according to a variety of international standards, such as European Pharmacopoeia (Avanafil EP), Avanafil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Avanafil USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty